top of page

Item List

Cision PR Newsire
Matterworks Announces Updates to its Board of Directors

Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors.

"Expansion of our Board of Directors is particularly timely as we approach the beta release in early 2023 and commercial launch in the summer of 2023 of Pyxis™, our next-generation machine learning software platform,'' said Mimoun Cadosch Delmar, Founder & CEO of Matterworks.

Recent Posts

Wavemaker 360 News


Episode 108: Jay Goss, General Partner at Wavemaker Three-Sixty Health ...

MedTech Money

Portfolio Company


Strados Labs forms collaboration with Boehringer Ingelheim for its Idiopathic Pu ...

Cision PR Newsire

Portfolio Company


Caduceus Capital Partners, Wavemaker Three-Sixty Health Co-Lead Series A Investm ...


surf break copy_edited_edited.jpg
bottom of page